According to Foster City, Calif.-based Gilead, Vemlidy is the first drug approved to treat this disease in almost a decade.
Vemlidy demonstrates similar antiviral efficacy at a dose one-tenth the size of Gilead’s other hepatitis B drug Viread, which gained FDA approval in 2001.
More articles on supply chain:
Trucking industry hopeful Trump will loosen regulations, increase road spending
Leverage data analytics to control cath lab costs
FDA updates citizen petition regulations to prevent delays in drug approvals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
